SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3p1w'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DBB_H_STRH229_1
(IGG1-KAPPA DB3 FAB
(HEAVY CHAIN)
IGG1-KAPPA DB3 FAB
(LIGHT CHAIN))
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 8 GLY A  13
GLY A  41
TYR A 417
VAL A 297
None
0.79A 1dbbH-3p1wA:
undetectable
1dbbL-3p1wA:
undetectable
1dbbH-3p1wA:
19.46
1dbbL-3p1wA:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZM_A_BZMA600_0
(ODORANT-BINDING
PROTEIN)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 8 VAL A 356
ASN A  72
GLY A  40
LEU A  14
None
0.89A 1dzmA-3p1wA:
1.8
1dzmA-3p1wA:
16.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W98_B_P1ZB1358_1
(PROSTAGLANDIN
REDUCTASE 2)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 6 ASP A 131
TYR A 220
PHE A 151
LEU A 193
None
1.17A 2w98A-3p1wA:
undetectable
2w98B-3p1wA:
undetectable
2w98A-3p1wA:
20.37
2w98B-3p1wA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YQZ_A_SAMA301_0
(HYPOTHETICAL PROTEIN
TTHA0223)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
5 / 12 ILE A 311
ALA A  44
ASP A  74
VAL A 394
LEU A  51
None
0.99A 2yqzA-3p1wA:
undetectable
2yqzA-3p1wA:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DZY_D_BRLD478_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 4 ILE A 124
GLN A 338
ILE A 347
LEU A 188
None
1.26A 3dzyD-3p1wA:
undetectable
3dzyD-3p1wA:
23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JZ0_B_CLYB900_1
(LINCOSAMIDE
NUCLEOTIDYLTRANSFERA
SE)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 8 TYR A 220
GLU A 133
PHE A 232
ILE A 233
None
0.95A 3jz0B-3p1wA:
undetectable
3jz0B-3p1wA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OND_A_ADNA506_2
(ADENOSYLHOMOCYSTEINA
SE)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
3 / 3 GLN A 326
THR A 327
LEU A 385
None
0.67A 3ondA-3p1wA:
undetectable
3ondA-3p1wA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OND_B_ADNB507_2
(ADENOSYLHOMOCYSTEINA
SE)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
3 / 3 GLN A 326
THR A 327
LEU A 385
None
0.66A 3ondB-3p1wA:
undetectable
3ondB-3p1wA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AFG_C_QMRC1214_1
(CAPITELLA TELETA
ACHBP)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 8 TYR A 286
CYH A 287
ILE A 411
ILE A 277
None
1.00A 4afgD-3p1wA:
undetectable
4afgE-3p1wA:
undetectable
4afgD-3p1wA:
18.50
4afgE-3p1wA:
18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LTW_A_486A303_1
(ANCESTRAL STEROID
RECEPTOR 2)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
5 / 9 LEU A 140
ALA A 134
PHE A 192
THR A 189
LEU A 185
None
1.38A 4ltwA-3p1wA:
undetectable
4ltwA-3p1wA:
19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BYK_A_OAQA302_0
(SULFOTRANSFERASE)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
5 / 12 ILE A 242
VAL A  87
LEU A  14
PHE A 246
THR A  93
None
1.17A 5bykA-3p1wA:
undetectable
5bykA-3p1wA:
18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D4N_C_ACTC201_0
(NITROGEN REGULATORY
PROTEIN P-II)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 5 VAL A 350
VAL A 104
GLY A 106
PHE A  79
None
0.79A 5d4nA-3p1wA:
1.6
5d4nC-3p1wA:
1.8
5d4nA-3p1wA:
12.00
5d4nC-3p1wA:
12.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_D_EY4D500_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 7 ILE A 333
GLN A 331
ALA A 368
THR A 369
None
0.75A 6cduC-3p1wA:
undetectable
6cduD-3p1wA:
undetectable
6cduC-3p1wA:
21.44
6cduD-3p1wA:
21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_E_EY4E500_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 8 ILE A 333
GLN A 331
ALA A 368
THR A 369
None
0.74A 6cduD-3p1wA:
undetectable
6cduE-3p1wA:
undetectable
6cduD-3p1wA:
21.44
6cduE-3p1wA:
21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_F_EY4F500_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
4 / 7 ALA A 368
THR A 369
ILE A 333
GLN A 331
None
0.81A 6cduF-3p1wA:
undetectable
6cduJ-3p1wA:
undetectable
6cduF-3p1wA:
21.44
6cduJ-3p1wA:
21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DM0_D_CYZD1302_0
(GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT)
3p1w RABGDI PROTEIN
(Plasmodium
falciparum)
5 / 9 PRO A 243
GLY A  13
SER A  20
LEU A 259
LEU A  33
None
1.48A 6dm0A-3p1wA:
undetectable
6dm0D-3p1wA:
undetectable
6dm0A-3p1wA:
10.48
6dm0D-3p1wA:
10.48